Commentary

Ex-Health Minister Tamura’s Clout Likely to Grow in Nagatacho

Lexicon

PMDA-WEST:
医薬品医療機器総合機構関西支部

The Column

3 Reasons Why KOL Management Is No Longer Enough

Archives

Takeda Aims for Consecutive Sales Growth through FY2022(Oct.31)
Sumitomo Dainippon’s Sales Down 1.7% on Drug Price Cuts in Japan(Oct.31)
Eisai Flounders in Japan, US Markets, Half-Year Profits Dive 60%(Oct.31)
Cabinet OKs Appointment of Keio Prof as Japan NIH Head(Oct.31)
Takeda Reports 2.8% Rise in First-Half Sales(Oct.31)

Most Read

1.
Health Ministry...
2.
MHLW Orders Rev...
3.
Global Pharma M...
4.
MHLW Orders Rev...
5.
Takeda Gains Wo...

News Calendar